| View |
|
DRP-12412-01
|
Losartan Potassium
|
Losartap
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Antagonist
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
03 October 2022
|
03 August 2025
|
| View |
|
DRP-11460-02
|
Citicoline (as sodium)
|
CHOLINEXCEL
|
250 mg/mL
|
Solution for Injection (IM/IV)
|
Psychostimulant and nootropic
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
09 June 2022
|
14 March 2027
|
| View |
|
DRP-8843-02
|
Ascorbic Acid
|
None
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)
|
Capsule
|
Vitamin
|
LifeSquare Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
07 July 2022
|
11 May 2025
|
| View |
|
DRP-9079-04
|
Sitagliptin (as phosphate)
|
Sitplixin 100
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
09 August 2022
|
31 October 2025
|
| View |
|
DRP-9079-03
|
Sitagliptin (as phosphate)
|
Gliptins
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
02 August 2022
|
31 October 2025
|
| View |
|
DRP-10423-01
|
Telmisartan
|
2Tel 40
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Hetero Labs Limited (Unit V)
|
India
|
CLIDP Conversion
|
24 March 2022
|
25 October 2026
|
| View |
|
DRP-9195-07
|
Ascorbic Acid + Zinc
|
Selcee Plus
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate)/10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamin/Mineral
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
01 June 2022
|
02 October 2028
|
| View |
|
DRP-11927-01
|
Meropenem
|
Tripem
|
1 g
|
Powder for Injection (IV)
|
Antibacterial (Carbapenem)
|
Uni Medicolabs Inc.
|
India
|
CLIDP Conversion
|
31 August 2022
|
20 May 2027
|
| View |
|
DRP-10424-01
|
Telmisartan
|
2Tel 80
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Hetero Labs Limited (Unit V)
|
India
|
CLIDP Conversion
|
22 March 2022
|
25 October 2026
|
| View |
|
DRP-11577-02
|
Ceftazidime (as pentahydrate)
|
Elbazid
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third Generation Cephalosporins)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
29 July 2022
|
31 March 2027
|
| View |
|
DRP-7074-07
|
Meropenem (as trihydrate)
|
Biopenem
|
1 g
|
Powder for Injection (IV)
|
Antibacterial
|
Daffodills Pharmaceuticals Ltd
|
India
|
CLIDP Conversion
|
26 April 2022
|
06 March 2027
|
| View |
|
DRP-11680-01
|
Thiamine Hydrochloride (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
Nervitamin
|
100 mg/ 5 mg/ 50 mcg
|
Capsule
|
VITAMIN
|
Eurasia Research Pharma Corporation
|
Philippines
|
CLIDP Conversion
|
02 June 2022
|
18 June 2025
|
| View |
|
DRP-12213-03
|
Cefuroxime (as axetil)
|
Eroxime-500
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
NGB Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
03 October 2022
|
13 July 2027
|
| View |
|
DRP-4745-01
|
MEFENAMIC ACID
|
MARIPAIN
|
500 mg
|
Capsule
|
NON STEROIDAL ANTI-INFLAMMATORY DRUG/ NSAID ( FENAMATE)
|
Eurasia Research Pharma Corporation
|
Philippines
|
Renewal
|
20 October 2024
|
18 September 2029
|
| View |
|
DRP-12408-04
|
Cefalexin (as monohydrate)
|
Ceplex
|
250 mg/5 mL
|
Powder for Suspension
|
Antibacterial (First Generation Cephalosporins)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
04 October 2022
|
21 July 2027
|
| View |
|
DRP-10623-02
|
Sitagliptin (as phosphate)
|
Januglip 100
|
100 mg
|
Tablet
|
Dipeptidyl peptidase 4 (DPP-4) Inhibitor
|
Hebei Tiancheng Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
28 February 2022
|
28 October 2026
|
| View |
|
DRP-11154-04
|
Nicardipine Hydrochloride
|
Afreedipine
|
1 mg/mL (10 mg/10 mL)
|
Solution for Injection (IV Infusion)
|
Calcium Channel Blocker
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
09 June 2022
|
11 February 2027
|
| View |
|
DRP-10868-01
|
Ascorbic Acid + Zinc
|
Healizinc
|
533.40 mg (equivalent to 600mg Sodium Ascorbate) + 10mg ( equivalent to 27.45mg Zinc Sulfate)
|
Capsule
|
Vitamin/Mineral
|
Eurasia Research Pharma Corporation
|
Philippines
|
CLIDP Conversion
|
30 May 2022
|
30 October 2025
|
| View |
|
HRP-185-11
|
Ascorbic Acid (as Sodium Ascorbate)
|
Unbranded
|
500 mg
|
Capsule (equivalent to 562.43 mg Sodium Ascorbate)
|
Vitamin
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
16 March 2023
|
28 January 2028
|
| View |
|
DRP-9885-08
|
Ascorbic Acid + Zinc
|
Dancee
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate) / 10mg (Equivalent to 70mg Zinc Gluconate)
|
Capsule
|
VITAMIN/MINERAL
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
12 May 2022
|
25 January 2026
|